Open-label extension data show fasedienol appears well tolerated and steadily improves social anxiety scores with as-needed intranasal use, as Vistagen plans FDA discussions.
|Poll|June 28, 2018
Mini Quiz: Panic Disorder
Author(s)Andrew W. Goddard, MD
Some patients with panic disorder have chronic, persistent symptoms. Take the quiz and learn more.
Advertisement
Which statement(s) are true of treatment resistant panic (TRP)?
Advertisement
Related to this article
Phase 3b data show centanafadine reduces adult ADHD and comorbid anxiety.
Single-dose DT120 ODT delivers rapid, sustained anxiety relief in phase 3 GAD trial, supporting FDA breakthrough path and NDA plans.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
Exploring a Misuse of Neuroscience: How Biology Has Been Used to Remove Responsibility in Youth
3
Treating PTSD Among Veterans at Risk for Suicide
4
Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD
5